V

VistaGen Therapeutics Inc
NASDAQ:VTGN

Watchlist Manager
VistaGen Therapeutics Inc
NASDAQ:VTGN
Watchlist
Price: 2.65 USD -2.75% Market Closed
Market Cap: 73.8m USD
Have any thoughts about
VistaGen Therapeutics Inc?
Write Note

P/OCF
Price to OCF

-2.1
Current
-2.5
Median
21.6
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-2.1
=
Market Cap
71.7m USD
/
Operating Cash Flow
-33.5m USD
All Countries
Close
 
US
V
VistaGen Therapeutics Inc
NASDAQ:VTGN
Average P/OCF: 20.4
Negative Multiple: -2.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -238 693.4
US
Abbvie Inc
NYSE:ABBV
19.1
US
Amgen Inc
NASDAQ:AMGN
20.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -141.7
US
Gilead Sciences Inc
NASDAQ:GILD
11.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -471.3
AU
CSL Ltd
ASX:CSL
31.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -76.1
NL
argenx SE
XBRU:ARGX
Negative Multiple: -138.1

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More